-
Mashup Score: 3
This cohort study assesses the long-term adverse effects and complications of prostate cancer treatment in treated patients compared with a general population of older males.
Source: jamanetwork.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 3
This cohort study assesses the long-term adverse effects and complications of prostate cancer treatment in treated patients compared with a general population of older males.
Source: jamanetwork.comCategories: General Medicine News, Oncologists1Tweet-
Analysis of 30K+ pts comparing long-term risks of adverse effects from #prostatecancer treatment to untreated control group. Quantified risk needed for informed decisions on PSA screening & treatment. @JAMAOnc: https://t.co/ombh7qky2W Press release: https://t.co/Ms9XHixDkR #pcsm https://t.co/506Y7jMDuY
-
-
Mashup Score: 0
A prostate cancer risk stratification strategy using artificial intelligence deep learning shows promise.
Source: www.renalandurologynews.comCategories: General Medicine News, UrologyTweet-
Deep learning multimodal artificial intelligence models outperformed current National Comprehensive Cancer Network (NCCN) risk groups in classifying metastasis risk in patients with localized #prostatecancer. #pcsm https://t.co/FSMW7mgx7a
-
-
Mashup Score: 3
This cohort study assesses the long-term adverse effects and complications of prostate cancer treatment in treated patients compared with a general population of older males.
Source: jamanetwork.comCategories: General Medicine News, Oncologists1Tweet-
Analysis of 30K+ pts comparing long-term risks of adverse effects from #prostatecancer treatment to untreated control group. Quantified risk needed for informed decisions on PSA screening & treatment. @JAMAOnc: https://t.co/ombh7qky2W Press release: https://t.co/Ms9XHixDkR #pcsm https://t.co/506Y7jMDuY
-
-
Mashup Score: 0
A prostate cancer risk stratification strategy using artificial intelligence deep learning shows promise.
Source: www.renalandurologynews.comCategories: General Medicine News, UrologyTweet-
Deep learning multimodal artificial intelligence models outperformed current National Comprehensive Cancer Network (NCCN) risk groups in classifying metastasis risk in patients with localized #prostatecancer. #pcsm https://t.co/FSMW7mgx7a
-
-
Mashup Score: 0Darolutamide Minimized Physical Decline in Patients With Prostate Cancer - Oncology Nurse Advisor - 1 month(s) ago
Physical function assessments with TUG and SPPB did not identify a decline in function among patients with CRPC receiving darolutamide over 24 weeks.
Source: www.oncologynurseadvisor.comCategories: General Medicine News, Oncologists1Tweet-
In a phase 2b study of men with castration-resistant #prostatecancer, treatment with the androgen receptor inhibitor darolutamide resulted in no clinically meaningful physical decline in most participants over 24 weeks. Published in @OncJournal. https://t.co/kK9spIXcwd #pcsm
-
-
Mashup Score: 3
This cohort study assesses the long-term adverse effects and complications of prostate cancer treatment in treated patients compared with a general population of older males.
Source: jamanetwork.comCategories: General Medicine News, Oncologists1Tweet-
Analysis of 30K+ pts comparing long-term risks of adverse effects from #prostatecancer treatment to untreated control group. Quantified risk needed for informed decisions on PSA screening & treatment. @JAMAOnc: https://t.co/ombh7qky2W Press release: https://t.co/Ms9XHixDkR #pcsm https://t.co/506Y7jMDuY
-
-
Mashup Score: 3
This cohort study assesses the long-term adverse effects and complications of prostate cancer treatment in treated patients compared with a general population of older males.
Source: jamanetwork.comCategories: General Medicine News, Oncologists1Tweet-
Analysis of 30K+ pts comparing long-term risks of adverse effects from #prostatecancer treatment to untreated control group. Quantified risk needed for informed decisions on PSA screening & treatment. @JAMAOnc: https://t.co/ombh7qky2W Press release: https://t.co/Ms9XHixDkR #pcsm https://t.co/506Y7jMDuY
-
-
Mashup Score: 3
This cohort study assesses the long-term adverse effects and complications of prostate cancer treatment in treated patients compared with a general population of older males.
Source: jamanetwork.comCategories: General Medicine News, Oncologists1Tweet-
Analysis of 30K+ pts comparing long-term risks of adverse effects from #prostatecancer treatment to untreated control group. Quantified risk needed for informed decisions on PSA screening & treatment. @JAMAOnc: https://t.co/ombh7qky2W Press release: https://t.co/Ms9XHixDkR #pcsm https://t.co/506Y7jMDuY
-
-
Mashup Score: 4Commercial prices and their influence on urology practices: Prostate cancer care among men with Medicare - 1 month(s) ago
This study examined the impact of commercial prices on the management of traditional Medicare beneficiaries with prostate cancer. Patients managed by practices facing higher commercial prices had low…
Categories: General Medicine News, Oncologists1Tweet-
How do commercial prices affect #ProstateCancer care in patients insured by Medicare? New research from @4rnav et al explains more: https://t.co/DCLmZlXjP0 @Oncoalert #PCSM CC: @WalterStadler5 https://t.co/Nz6nRycqvT
-
Analysis of 30K+ pts comparing long-term risks of adverse effects from #prostatecancer treatment to untreated control group. Quantified risk needed for informed decisions on PSA screening & treatment. @JAMAOnc: https://t.co/ombh7qky2W Press release: https://t.co/Ms9XHixDkR #pcsm https://t.co/506Y7jMDuY